Comera Life Sciences Holdings, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-12-27: Reporting owner Cherington Charles; Form 4; Security Series A Convertible Perpetual Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-12-27 | Cherington Charles 10% Owner | 4 | Series A Convertible Perpetual Preferred Stock Derivative · Indirect · (m) | P Open market or private purchase of non-derivative or derivative security | $500,000.00 | 2024-01-03 |